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ABSTRACT
Endocrine therapy agents (the selective estrogen receptor (ER) modulators 
such as tamoxifen or the selective ER down-regulators such as ICI 182,780) are 
key treatment regimens for hormone receptor-positive breast cancers. While these 
drugs are very effective in controlling ER-positive breast cancer, many tumors 
that initially respond well to treatment often acquire drug resistance, which is a 
major clinical problem. In clinical practice, hormonal therapy agents are commonly 
used in combination or sequence with radiation therapy. Tamoxifen treatment 
and radiotherapy improve both local tumor control and patient survival. However, 
tamoxifen treatment may render cancer cells less responsive to radiation therapy. 
Only a handful of data exist on the effects of radiation on cells resistant to 
hormonal therapy agents. These scarce data show that cells that were resistant to 
tamoxifen were also resistant to radiation. Yet, the existence and mechanisms of 
cross-resistance to endocrine therapy and radiation therapy need to be established.
Here, we for the first time examined and compared radiation responses of MCF-7 
breast adenocarcinoma cells (MCF-7/S0.5) and two antiestrogen resistant cell lines 
derived from MCF-7/S0.5: the tamoxifen resistant MCF-7/TAMR-1 and ICI 182,780 
resistant MCF-7/182R-6 cell lines. Specifically, we analyzed the radiation-induced 
changes in the expression of genes involved in DNA damage, apoptosis, and cell 
cycle regulation. We found that the tamoxifen-resistant cell line in contrast to the 
parental and ICI 182,780-resistant cell lines displayed a significantly less radiation-
induced decrease in the expression of genes involved in DNA repair. Furthermore, 
we show that MCF-7/TAMR-1 and MCF-7/182R-6 cells were less susceptible to 
radiation-induced apoptosis as compared to the parental line. These data indicate 
that tamoxifen-resistant breast cancer cells have a reduced sensitivity to radiation 
treatment. The current study may therefore serve as a roadmap to the future analysis 
of the mechanisms of cross-resistance between hormonal therapy and radiation.
INTRODUCTION
Endocrine therapy is a widely accepted treatment 
of choice for hormone receptor-positive breast cancers in 
early stages and during advanced metastasis [1]. Women 
with estrogen receptor- (ER) and/or progesterone receptor 
(PR) positive breast cancers are the best candidates for 
hormone therapy [2]. The ERα-positive normal breast 
cells may produce growth factors that stimulate the 
proliferation of neighboring cells leading to breast 
cancer development. In contrast, ERβ is essential for 
breast tissue differentiation, and its loss is associated 
with breast carcinogenesis [3]. The selective estrogen 
receptor modulators (SERMs) such as Tamoxifen bind 
to the ligand-binding domain (LBD) of ER preventing 
its stimulation by estrogen, while the selective estrogen 
receptor down-regulators (SERDs) such as ICI 182,780 
(Fulvestrant, Faslodex) bind, block and increase the 
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degradation of ER [3, 4]. Both drugs are currently 
established as effective treatment therapy with beneficial 
outcomes. Unfortunately, in the case of advanced disease, 
acquired resistance to both drugs inevitably develops, 
which is a major clinical problem [5-8]. Drug resistance is 
usually accompanied with an aggressive cell behavior and 
invasiveness. The evidence exists that the main mechanism 
of hormone therapy resistance is the deregulation of 
growth factor-signaling cascades. The over-expression of 
growth factors, their receptors and downstream signaling 
elements promotes hormone therapy failure [8-10]. Long-
term estrogen-deprived tumor cells may adapt to low 
levels of estrogen by increasing their sensitivity to it [11]. 
Such enhanced sensitivity to estrogen may result from the 
activation of several signaling pathways such as RAS, 
RAF, MEK and MAPK [12, 13]. Moreover, it has been 
shown that tamoxifen- and fulvestrant- resistant MCF-7 
cells overexpress receptors in the HER family, e.g. EGFR 
and HER2 [5-7, 9, 10, 14]. The overexpressed EGFR and 
HER2 are well known to recruit MAPK, AKT and PKC 
signaling cascades [15-17]. 
The combination of hormone therapy and radiation 
is widely used in clinical practice. The application of 
tamoxifen and radiotherapy is believed to improve both 
local control and patient survival [18, 19]. Nevertheless, 
a suspicion also exists that tamoxifen may render cancer 
cells less responsive to radiotherapy by providing a 
protective effect against radiation. Early studies on cell 
culture have shown that tamoxifen causes an arrest of 
cells in the radioresistant G0/G1 phase of the cell cycle 
reducing the radiosensitivity of tumor cells pretreated 
with tamoxifen [20-23]. Today, the most important clinical 
concern is the optimal scheduling (either concurrent 
or sequential) of radiation and hormonal therapy 
administration [24, 25]. Even less data and evidence exist 
on the radiation response of cells resistant to hormonal 
therapy, which we believe is important considering 
the great incidence of resistance to systemic therapy in 
patients with breast cancer. In their study, Paulsen and 
colleagues investigated the influence of radiation on 
different breast cancer cell lines including cells resistant 
to tamoxifen (MCF-7/TAMR-1). The results of the study 
showed that the MCF-7/TAMR-1 cells were more resistant 
to ionizing radiation than the MCF-7 and MDA-MB-231 
cell lines [22].
In this study, we analyzed gene expression 
changes during radiation responses in MCF-7 breast 
adenocarcinoma cells (MCF-7/S0.5) and in the tamoxifen 
resistant cell line MCF-7/TAMR-1 and the faslodex 
resistant cell line MCF-7/182R-6 derived from the MCF-7/
S0.5 cell line. For the first time, we have shown that MCF-
7/TAMR-1 cells have an elevated potential to withstand 
radiation-induced DNA damage and display a decreased 
sensitivity to ionizing radiation. 
RESULTS
The effects of radiation on whole-genome 
gene expression in antiestrogen-sensitive and 
antiestrogen-resistant MCF-7 cells
The gene expression analysis was conducted for 
MCF-7/S0.5 and the antiestrogen-resistant derivatives, 
MCF-7/TAMR-1 and MCF-7/182R-6, with the purpose 
to evaluate and compare the radiation response between 
cell lines. Differential gene expression in the MCF-7 
cell lines was found upon exposure to radiation. In fact, 
the expression level of 402, 371 and 187 genes was 
significantly altered due to X-ray exposure in MCF-7/
S0.5, MCF-7/182R-6 and MCF-7/TAMR-1, respectively 
(Fig.1). Interestingly, most of the altered genes were 
down-regulated. Amongst 134 genes that were common 
for all three cell lines, 27 genes were up-regulated and 
107 genes were down-regulated. The majority of gene 
expression changes observed in the antiestrogen resistant 
cell lines were also seen in the parental MCF-7/S0.5, (73.6 
and 73.8% of the genes in MCF-7/182R-6 and in MCF-7/
TAMR-1, respectively). The least gene expression changes 
were found in the MCF-7/TAMR-1 cell line which had 
only half as many gene changes as the parental and ICI 
182,780 resistant cells, and only 30 unique genes changes 
in response to radiation treatment (Fig.1). Further, we 
uploaded the gene lists consisting of 402, 371 and 187 
genes from the MCF-7/S0.5, MCF-7/182R-6 and MCF-7/
TAMR-1 lines, respectively, through the DAVID pathway-
specific enrichment analysis in order to identify casual 
relationships between the genes and organize them 
into specific pathways according to their functions. 
Subsequently, the genes with similar or identical functions 
were grouped together and organized by the KEGG 
database into pathways. The least number of genes that 
could constitute a pathway was three; therefore, only 83 
genes and the 12 pathways they belong to were further 
studied (Suppl Table 1). Mainly, those were the genes that 
play a role in cell cycle, DNA replication, base excision 
repair (BER), nucleotide excision repair (NER), mismatch 
repair (MMR), homologous recombination (HR), p53 
signaling, gap junction, drug metabolism, purine and 
pyrimidine metabolism and spliceosome. Based on each 
gene’s function and its expression trend, the roles of the 
above-mentioned pathways were evaluated and compared 
between cell lines (Suppl Table 1 and Table 1). For this, 
the pathways were deemed significantly altered if at 
least 80% of the genes from the pathway were shifting 
the pathway in the same direction (Table 1) [26]. For 
instance, in the MCF-7/S0.5 line, eight out of ten genes 
from the p53 signaling pathway represented in Suppl 
Table 1were changed in a way that functionally shifted the 
pathway to the overall up-regulation. These eight genes 
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Figure 1: Gene expression profiling of MCF-7/S0.5, MCF-7/TAMR-1 and MCF-7/182R-6. The Venn diagram shows the 
number of significantly changed genes in the MCF-7/S0.5, MCF-7/TAMR-1 and MCF-7/182R-6 cell lines upon radiation in comparison 
to their corresponding un-irradiated controls, as identified by the gene expression profiling analysis. The arrows beside the numbers in 
brackets represent the direction of genes alteration (up- or down-regulation).
Figure 2: Fold change in the levels of CCNA2, CCNB2, CDC20, PTTG1 and BAX transcripts detected by qRT-PCR. 
Each treatment group was compared to its corresponding control. Actin was used as a reference gene (calculated by Pfaffl). * - significant, 
p<0.001; ** - significant, p<0.01. (Student’s t-test). 
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represented 80% of pathway significance in the MCF-
7/S0.5 line, which allowed us to conclude that the p53 
signaling pathway was significantly up-regulated in the 
MCF-7/S0.5 cells upon exposure to radiation (Table 1). An 
identical analysis approach was applied for the remaining 
11 pathways in each cell line. Table 1 demonstrates the 
pathways’ specific differences between MCF-7/S0.5, 
MCF-7/182R-6 and MCF-7/TAMR-1 in response to X-ray 
radiation (Table 1). As expected, 5 Gy of X-ray caused cell 
cycle deregulation in all three MCF-7 cell lines (Suppl. 
Fig. 1). The down-regulation in the expression level of 
18 genes involved in cell cycle was common for MCF-7/
S0.5, MCF-7/TAMR-1 and MCF-7/182R-6. These genes 
constituted the components of the mitotic checkpoint 
CHEK, MAD2L1, BUB1 and BUB1B, E2F transcription 
factor 2, CCNA2 and CCNB2 encoding cyclins A2 and 
B2, cyclin-dependant kinase CDC20, the components 
of the minichromosome maintenance (MCM) complex, 
protein-kinase TTK, protease ESPL11 and a regulator of 
chromosome stability PTTG1. In addition, MCF-7/S0.5 
and MCF-7/182R-6 shared the down-regulation of RAD2, 
CDC25C, CDC7, CDK2 and a negative regulator of entry 
into mitosis PKMYT. Both antiestrogen-resistant cell lines 
overexpressed growth arrest and GADD45A, a DNA-
damage-inducible factor, upon radiation treatment (Suppl 
Table1). The second pathway that like the cell cycle was 
mostly affected by ionizing radiation in all cell lines was 
DNA replication. 20, 16 and 9 genes involved in the 
process of DNA replication were down-regulated in MCF-
7/S0.5, MCF-7/182R-6 and MCF-7/TAMR-1, respectively 
(Table 1). Specifically, they were components of the 
minichromosome complex (MCM 2-7), DNA polymerases 
A, D and E, replication factors RFC 2, 3, 4, and 5, the 
replication protein RPA3 and others (Table 1). Moreover, 
the main DNA repair pathways were also downregulated 
in MCF-7/S0.5 and MCF-7/182R-6 in response to 5 
Gy of X-rays. Base excision repair, mismatch repair, 
and homologous recombination were down-regulated 
in MCF-7/S0.5 and MCF-7/182R-6; and nucleotide 
excision repair (NER) was significantly down-regulated 
in MCF-7/S0.5 (Suppl Table 1 & Table 1). Moreover, 
the purine and pyrimidine metabolism pathways that 
could contribute to DNA replication and DNA repair 
by providing the necessary deoxyribonucleotides were 
also down-regulated in response to X-ray radiation. An 
inability of cells to ultimately replicate and repair their 
DNA leads to cell death. The P53 signaling pathway 
was functionally up-regulated in MCF-7 sensitive and 
antiestrogen-resistant cell lines in response to exposure 
to radiation (Table 1). The decreased expression of 
Table 1: The significantly altered KEGG pathways in MCF-7/S0.5, MCF-7/TAMR-1 and MCF-7/182R-6 
cells after X-ray treatment in comparison to the corresponding un-treated controls. In this table, the pathway 
significance (%) is defined as the ratio of gene alterations that similarly affect a certain pathway (either up- or down-regulate) 
to the total number of altered genes in the pathway. “+” – the pathway is up-regulated; “-” – the pathway is down-regulated. 
Numbers in brackets represent the total number of altered genes in the pathways. “N/S” – not significant, which could be due to 
either less than 80% significance or less than 3 of the total number of genes altered in the pathway.
Pathway MCF-7/S0.5 MCF-7/182R-6 MCF-7/TAMR-1
BER -100% (9) -100% (7) -
Cell cycle -100% (25) -100% (25) -100% (19)
DNA replication -100% (20) -100% (16) -100% (9)
Drug metabolism - - +100% (3)
Gap junction -100% (8) -100% (7) -
HR -100% (6) -100% (4) -
MMR -100% (7) -100% (6) -
NER -81.8% (11) N/S (9) N/S (4)
P53 signaling +80% (10) +84.6% (13) +88.95 (9)
Purine metabolism -90.9% (11) - -
Pyrimidine metabolism -92.3% (13) -87.5% (8) -100% (5)
Spliceosome - -100% (7) -
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tubulins, the main components of microtubules, resulted 
in the overall down-regulation of the gap junction 
pathway in MCF-7/S0.5 and MCF-7/182R-6 cells which 
could contribute to the apoptotic response; the down-
regulation of spliceosome in MCF-7/182R-6 is translated 
into the absence of RNA processing that is necessary for 
protein synthesis and cell proliferation. Interestingly, an 
increase in the expression state of genes that contribute 
to drug metabolism was observed in the MCF-7/TAMR-
1 cell line after radiation treatment. These genes were: 
flavin- containing monooxygenase (FMO5), glutathione 
S-transferase kappa 1 (GSTK1) and monoamine oxidase 
A (MAOA) that could potentially increase drug-resistance 
of MCF-7/TAMR-1 cells. Overall, although the radiation 
response of the three MCF-7 cell lines was similar in 
the way that all cells showed down-regulation of cell 
cycle, DNA replication, DNA repair and activation of the 
apoptotic pathway, the most dramatic response was found 
in the antiestrogen sensitive MCF-7/S0.5 cell line. The 
cells resistant to ICI 182,780 were also very sensitive to 
radiation, while tamoxifen-resistant cells showed the least 
dramatic response. Moreover, the up-regulation of the drug 
Figure 3: Radiation-induced H2AX phosphorylation in MCF-7/S0.5, MCF-7/TAMR-1 and MCF-7/182R-6 cells. The 
results on the pictures and a figure below are presented as an average number of γH2AX foci per cell ± SE, n = 200. * - significantly 
different from the respective control; p < 0.05; # - significantly different from MCF-7/S0.5 cell line. Controls were not significantly 
different between three cell lines; p<0.05. Magnification, × 100. Blue – DAPI, green – γH2AX.
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metabolism pathway post-radiation exposure suggests 
a possible strengthening of drug resistance by ionizing 
radiation in MCF-7/TAMR-1 cells. The gene expression 
data have been confirmed by the qRT-PCR analysis on the 
five genes that play a role in the cell cycle and apoptosis: 
CCNA2 and CCNB2, CDC20, PTTG1 and BAX. Similarly 
to the gene expression data, qRT-PCR showed a significant 
down-regulation of CCNA2, CCNB2, CDC20, PTTG1 
and up-regulation of BAX in the three MCF/7 cell lines 24 
hours after radiation exposure (Fig.2). 
Radiation-induced DNA damage in MCF-7/S0.5, 
MCF-7/182R-6 and MCF-7/TAMR-1
The gene expression changes found in the three 
MCF-7 lines, MCF-7/S0.5, MCF-7/182R-6 and MCF-7/
TAMR-1, were accompanied with the extensive DNA 
damage caused by radiation. Ionizing radiation (IR) is a 
potent DNA-damaging agent capable of inducing cross 
-linking, nucleotide base damage, and most importantly, 
single- and double-strand breaks (DSBs) which are well-
known inducers of apoptosis [27, 28]. Therefore, we 
analyzed and compared the levels of IR-induced DNA 
damage in MCF-7/S0.5, MCF-7/182R-6 and MCF-7/
TAMR-1 cells by detecting γH2AX foci, a well accepted 
indicator of DNA double-strand breaks [29] and by 
the Comet assay. To better study the dynamics of the 
appearance of γH2AX foci in MCF-7 breast cancer cells, 
we added another time point (30 minutes) and a lower 
IR dose (0.5 Gy) to the already existing experimental 
conditions. As expected, the appearance of γH2AX foci 
in all three cell lines was dose-, and time-dependant. Both 
the intermediate (0.5 Gy) and high (5 Gy) doses of X-rays 
caused a significant elevation in the level of γH2AX foci 
in antiestrogen-sensitive and antiestrogen-resistant cells 
(Fig.3). The highest γH2AX level was observed at the 
30-minute time point. Specifically, 12.1-, 7.84-, and 6.07-
fold changes compared to controls were caused by 0.5 
Gy; and 27.3-, 20.5-, and 14.8-fold changes were caused 
Figure 4: Radiation-induced DNA damage in MCF-7/S0.5, MCF-7/TAMR-1, and MCF-7/182R-6 cells as determined 
by the Alkaline Comet assay. The graphs represent the percentage of DNA in the comet tails (tail intensity) obtained by the Alkaline 
Comet assay performed on MCF-7/S0.5, MCF-7/TAMR-1, and MCF-7/182R-6 cells 30 minutes, 6 and 24 hours after X-ray irradiation. Tail 
intensity levels are represented as mean ± SD; * - significantly different from the respective control, p < 0.01; ** - significantly different 
from the respective control, p<0.05. (Student’s t-test). Comet representative pictures of tail intensity are located beside the charts.
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by 5 Gy of X-rays 30 minutes after exposure in MCF-7/
S0.5, MCF-7/TAMR-1 and MCF-7/182R-6, respectively 
(Fig.3). Here, it is important to note that 30 minutes after 
exposure to 0.5 and 5 Gy of X-rays both antiestrogen-
resistant cell lines accumulated significantly less DSBs 
than their antiestrogen-sensitive parental line MCF-7/
S0.5 line. Approximately a halfway decrease in the level 
of γH2AX foci was achieved from the 30-min to 24-h time 
point in all three cell lines indicating DNA repair and/or 
damage-induced apoptosis during this period. Therefore, 
at the 24-hour time point, the level of foci was different 
from that in the control non-radiated cells by 4.12-, 3.03-
, and 3.11-fold for the 0.5 Gy dose and by 8.71-, 5.11-
, and 8.73-fold for the 5 Gy dose of X-rays in MCF-7/
S0.5, MCF-7/TAMR-1 and MCF-7/182R-6, respectively 
(Fig.3). Interestingly, MCF-7/TAMR-1 cells displayed 
more complete repair of IR-induced DNA damage than the 
other two lines 24 hours after exposure to 5 Gy of X-rays. 
The number of γH2AX foci in tamoxifen-resistant MCF-
7/TAMR-1 cells at this time point was significantly lower 
than in other cell lines. Overall, the immunofluorescent 
analysis showed that the background level of γH2AX foci 
was similar for the three cell lines, and the induction of 
foci by radiation had a similar trend between the MCF-
7/S0.5 cell line and the two anti-estrogen-resistant cell 
lines, MCF-7/TAMR-1 and MCF-7/182R-6. Nevertheless, 
MCF-7/S0.5 cells displayed significantly higher level of 
DNA DSBs after each applied dose in comparison to the 
antiestrogen-resistant cells. Additionally, MCF-7/TAMR-
1 cells were able to repair IR-induced damages 24 hours 
after irradiation more efficiently than the other two lines. 
In the comet assay, the super coiled duplex DNA 
underwent unwinding and denaturation under strong 
alkaline conditions [30]. This led to the reduction of 
DNA fragment size and the expression of alkali labile 
sites as single-strand breaks which are stretched out by 
electrophoresis. A comet tail consisting of the broken 
or damaged DNA fragments was analyzed through the 
intensity in MCF-7/S0.5, MCF-7/TAMR-1 and MCF-
7/182R-6 cells after radiation treatment (Fig.4). A 5 Gy 
X-ray treatment led to significant damage in MCF-7 
parental and both drug resistant cells immediately (30 
min) after the application. These damages are believed to 
represent DSBs, SSBs, alkali labile sites, and breaks from 
replication events. But the persistence of damages was 
only observed in MCF-7/S0.5, and MCF-7/182R-6 cells at 
the 6- and 24-hour time points, and no significant damages 
were observed in the drug-resistant line MCF-7/TAMR-1 
(Fig.4). Such difference could be associated with a higher 
potential for DNA repair in cells resistant to tamoxifen. 
Radiation-induced apoptosis in MCF-7/S0.5, 
MCF-7/TAMR-1 and MCF-7/182R-6 cells 
IR exposure is known to induce apoptotic cell 
death. Therefore, we analyzed the levels of IR-induced 
apoptosis in MCF-7/S0.5 and two antiestrogen-resistant 
lines, MCF-7/182R-6 and MCF-7/TAMR-1. Early apoptosis 
is characterized by various changes in the cellular plasma 
membrane; the primary change is the translocation of 
phosphatidylserine (PS) from the inner layer to the 
surface of the membrane. Annexin V possesses a high 
affinity to PS, and this allows for the early detection of 
apoptotic changes [31]. Here, we analyzed IR-induced 
apoptosis using an Annexin V assay for MCF-7 breast 
adenocarcinoma cells 24 h post radiation exposure. 
Interestingly, 0.5 Gy of X-rays did not cause any 
significant changes in the level of early apoptosis in either 
of cell lines. In contrast, 5 Gy X-rays led to a significant 
apoptosis in all three cell lines (Fig.5). The percentage of 
annexin V-positive cells increased from 4.96 % to 30.0 % 
in MCF-7/S0.5; from 7.98% to 14.1 % in MCF-7/182R-6; 
and from 1.7 % to 6.04 % in MCF-7/TAMR-1 at 5 Gy of 
irradiation at 24 hours post radiation (Fig.5). Overall, the 
annexin V assay showed that the antiestrogen-sensitive 
MCF-7/S0.5 line is more sensitive to radiation-induced 
apoptosis than the antiestrogen-resistant MCF-7/182R-6 
and MCF-7/TAMR-1 lines. 
DISCUSSION
The effect of systemic therapy on patients with 
breast cancer has been widely debated. A variety of 
alternatives for breast cancer treatment are constantly 
expanding but the combination of chemotherapy, radiation 
therapy, surgery and hormone therapy for the appropriate 
treatment plan is still complex [32]. Although these 
therapies have proven to be beneficial, a large number of 
patients acquire resistance to treatments. 
The purpose of this study was to investigate 
radiation-induced gene expression changes in three cell 
lines of breast adenocarcinoma: the parental MCF-7/
S0.5 and the antiestrogen- resistant MCF-7/TAMR-1 
and MCF-7/182R-6. Using microarray technology tools, 
we were able to screen differences in gene expression 
in response to radiation between MCF-7/S0.5, MCF-7/
TAMR-1 and MCF-7/182R-6. Here, we show that these 
three cell lines respond differently to radiation at the 
gene expression level. Gene expression profiling showed 
that the expression level of at least 402 and 371 genes 
changed in the antiestrogen-sensitive MCF-7/S0.5 cell 
line and in cells resistant to ICI 182,780, respectively, due 
to 5 Gy X-rays. However, in MCF-7/TAMR-1 cells, only 
187 genes changed (Fig.1). We believe that the ability of 
cells to retain their gene expression potential at a close to 
constant level regardless of DNA-damaging insults may 
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be due to some features acquired by antiestrogen-resistant 
cells and shared in other forms of resistance, such as 
radiation resistance. Interestingly, most of the changed 
genes were down-regulated in all three cell lines. Using 
David software, we have revealed that these genes belong 
mainly to the cell cycle, DNA replication and DNA repair 
pathways (Suppl Table 1). The most profound down-
regulation of gene expression was observed in genes 
involved in the cell cycle pathway (Table 1, Suppl. Fig.1). 
The reduced expression of the S and M cyclins, cyclin 
A2 and B2 (Fig.2), and their cyclin-dependant kinase 
CDK2 indicate cell cycle arrest in S or G2/M phases of 
the cell cycle (Suppl Table 1, Suppl. Fig.1). Moreover, the 
similar down-regulation of the E2F transcription factor 
Figure 5: Radiation-induced apoptosis in MCF-7/S0.5, MCF-7/TAMR-1 and MCF-7/182R-6 cells. The number of cells in 
early apoptosis was measured using the Annexin V-FITC assay for control cells (CT) and cells irradiated with 0.5 Gy and 5 Gy of X-rays. 
M1 – AnnexinV- positive cells; Viable cells - AnnexinV- and PI-negative (the lower left quadrants); Cells in the early apoptosis state - 
AnnexinV-positive and PI-negative (the lower right quadrants); Cells in the late apoptosis state or already dead cells - both Annexin V- and 
PI-positive (the upper right quadrants).
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may prevent cells from entering the S-phase. In addition, 
the lower expression of PTTG1, the TTK protein kinase 
that is usually present in rapidly proliferating cells, (Fig.2) 
that peaks in the M phase, ORC3L that binds to origins 
of replication, CDC7, one of the regulators of the G1/S 
transition, CDC25C, an inducer of mitotic control that is 
necessary for cell cycle progression, and CDC20 (Fig.2), 
an activator of APC and a major regulator of cell division, 
reflects cell cycle disturbance in all three cell lines. One 
would expect that the cells were arrested at the cell 
cycle checkpoints, but surprisingly, most of the mitotic 
checkpoint regulators were also down-regulated. Among 
them were: CHEK1 that phosphorylates the components 
of CDC25 for cell cycle arrest; MAD2 that interacts 
with CDC20 and is a component of the spindle-assembly 
checkpoint that prevents anaphase until chromosomes 
are correctly aligned, and BUB1 that is involved in cell 
cycle checkpoint enforcement (Suppl Table1). These gene 
expression data represent the total cell-cycle shutdown 
and checkpoint failure which are most probably due to 
extensive DNA damages caused by ionizing radiation. 
Cell cycle checkpoints usually contribute to cell 
survival allowing for DNA damage repair; and the lack 
of checkpoints makes cells more sensitive to killing by 
ionizing radiation [33].
Both the cell cycle and DNA replication pathways 
shared the common down-regulation of six components 
of the minichromosome maintenance complex (MCMs: 2, 
3, 4, 5, 6, 7) in all three cell lines (Suppl Table 1, Suppl. 
Fig.1). The MCM 2-7 helicase complex is important for 
the replication fork formation and elongation during DNA 
replication [34]. In fact, it is required for the assembly of 
pre-replication complexes (pre-RCs) at replication origins 
at the end of mitosis and during late G1 [35, 36]. It is 
evident that mammalian cells decrease the rate of ongoing 
DNA synthesis in response to DNA damage at the level 
of origin initiation and fork progression [37]. Obviously, 
the inactivation of the MCM complex inhibits DNA 
replication and cell proliferation and can be the mechanism 
of cell cycle arrest. Indeed, the down-regulation of MCM2 
and MCM6 was associated with Notch-dependant cell 
cycle arrest in endothelial cells and human fibroblasts [38]. 
In response to genotoxic stress such as ionizing radiation, 
the ATM/ATR checkpoint pathways are activated and 
target stalled replication forks. The MCM complex is also 
a target of checkpoint signaling [39]. Stalled replication 
forks must retain MCM proteins in order to resume 
replication. Otherwise, replication licensing cannot be 
reassembled as origins fire only once in each cell cycle 
[36]. The down-regulation of MCM 2-7 in MCF-7/S0.5, 
MCF-7/TAMR-1 and MCF-7/182R-6 (Suppl Table 1) 
in response to X-ray radiation indicates aberrant DNA 
replication or its absence and cell cycle arrest. In addition, 
reduced expression levels of DNA polymerases add up to 
the disruption of DNA replication and/or repair. Here, it 
is important to emphasize that mainly DNA polymerases 
from MCF-7/S0.5 and MCF-7/182R-6 are inhibited, and 
only polymerase PolE2 is also effected in MCF-7/TAMR-
1 (Suppl Table 1). The other necessary components 
of the DNA replication/repair pathway which were 
down-regulated in response to ionizing radiation were: 
LIG1 (a ligase that seals nicks in double-stranded DNA 
during replication, recombination and repair), PRIM1 (a 
primase that synthesizes short RNA primers for Okazaki 
fragments during discontinuous replication), FEN1 
(an endonuclease that cleaves the 5’-overhanging flap 
structure that is generated by displacement synthesis when 
DNA polymerase encounters the 5’-end of a downstream 
Okazaki fragment), RNASEH2A (a ribonuclease that 
removes RNA primers from lagging-strand Okazaki 
fragments), RFC 2-5 (replication factors that play a role 
of a clamp loader for loading PCNA on DNA during 
replication), and RPA3 (the replication protein that binds 
ssDNA and keeps it unwound for DNA replication or 
repair). Overall, 20, 16 and 9 DNA replication genes 
were down-regulated in MCF-7/S0.5, MCF-7/182R-6 and 
MCF-7/TAMR-1, respectively. Furthermore, the detected 
down-regulation of purine and pyrimidine metabolism 
mainly in MCF-7/S0.5 and MCF-7/182R-6 contributes 
to the decreased DNA replication/repair. The importance 
of sufficient nucleotide pools in the S phase is reflected 
by the G1 arrest when the pools are inadequate [40]. 
Further evaluation of genes by functional relationships 
with pathways showed the similarity in the radiation 
response between MCF-7/S0.5 and MCF-7/182R-6 (Table 
1). Both cell lines exhibited a lower expression of DNA 
repair genes following radiation exposure. Specifically, 
the down-regulation of base excision repair, nucleotide 
excision repair, mismatch repair and homologous 
recombination was observed. In addition to the previously 
mentioned genes (DNA polymerases, RFCs, RPAs, FEN1 
and LIG1) that clearly participate in DNA repair, some 
specific repair genes were also down-regulated (Suppl 
Table 1). These genes were the following: uracil-DNA 
glycosylase (UNG that excises uracil residues from DNA 
that can arise as a result of misincorporation of dUMP 
residues by DNA polymerase or due to the deamination 
of cytosine); poly(ADP-ribose) polymerase 2 (PARP2 
that catalyzes the poly ADP-ribosylation of a limited 
number of acceptor proteins involved in chromatin 
architecture and DNA metabolism) and high-mobility 
group box1-like1 (HMGB1L1 that binds preferentially 
single-stranded DNA and unwinds double-stranded DNA) 
in BER; mutS homolog 6 (MSH6 that heterodimerizes 
with MSH2 to form MutS alpha that binds to DNA 
mismatches, thereby initiating DNA repair) in MMR; 
Bloom syndrome, REcQ helicase-like (BLM that unwinds 
single- and double-stranded DNA in a 3’-5’ direction); 
RAD51 homolog C (RAD51C that is involved in the 
homologous recombination repair pathway of double-
stranded DNA breaks arising during DNA replication 
or induced by DNA-damaging agents); RAD54-like 
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(RAD54L that is involved in DNA repair and mitotic 
recombination) and X-ray repair complementing defective 
repair in Chinese hamster cells 3 (XRCC3 that is thought 
to repair chromosomal fragmentation, translocations 
and deletions) in HR. Interestingly, two genes involved 
in NER, damage-specific DNA binding protein (DDB2) 
and xeroderma pigmentosum complementation group C 
(XPC) involved in DNA damage recognition and initiation 
of DNA repair were up-regulated in MCF-7/S0.5 and 
MCF-7/182R-6. This might mean that DNA damages are 
initially recognized, but the actual repair failed due to the 
lack of downstream components of the pathway. Such 
results demonstrate that radiation-induced DNA damages 
(especially in MCF-7/S0.5 and MCF-7/182R-6) are too 
great for cell survival and lead to DNA repair failure 
and possibly to cell death. In contrast, there were no 
significant changes in the expression level of DNA repair 
genes in MCF-7/TAMR-1 cells. The immunocytochemical 
staining of cells for γH2AX proved the radiation-induced 
formation of DNA damages, specifically DSBs, and 
the initiation of DNA repair in all three cell lines. The 
induction of the DSBs was dose- and time-dependant 
(Fig.3). Although many DSBs were repaired in 24 hours, 
the level of γH2AX never returned to the initial one. At 
the 24-hour time point, a lot of DSBs caused by both low 
and high doses remained unrepaired in all three cell lines. 
Interestingly, MCF-7/TAMR-1 cells displayed significantly 
lower levels of γH2AX foci at 24 hours upon exposure to 5 
Gy of X-rays in comparison to the other two cell lines that 
were shown to be DNA repair defective in gene expression 
analysis. Considering, that γH2AX staining only detects 
DSB damages in DNA, we performed the Comet assay 
to evaluate the broader types of damages. These damages 
are believed to represent DSBs, SSBs, alkali labile sites, 
and breaks from replication events. Although, all three 
cell lines displayed a rapid increase (30 minutes) in the 
levels of radiation-induced DNA damage, MCF-7/TAMR-1 
cells showed no significant persistence of DNA damages 
(Fig.4). 6 and 24 hours after radiation exposure, the level 
of DNA damages represented by the comet tail intensity 
was similar to the control level in MCF-7/TAMR-1 cells. 
In contrast, the level of DNA damages in MCF-7/S0.5 
and MCF-7/182R-6 cells remained high even at 24 hours 
post radiation. These data suggest that MCF-7/TAMR-1 
cells have a higher DNA repair activity after radiation in 
comparison to MCF-7/S0.5 and MCF-7/182R-6 cells. The 
ability to withstand and repair DNA damage may result 
in reduced sensitivity to radiation and possibly demands 
other types of cancer treatment. 
The majority of DNA damage signaling proteins 
may be inactivated by caspases during the execution phase 
of apoptosis [41]. P53 is one of the main executioners 
of cellular response to ionizing radiation and apoptosis. 
Its levels are elevated in response to ionizing radiation 
affecting a number of downstream effector genes, such 
as Bax, p21, GADD45G and Mdm2 [41]. Radiation-
induced p53 activation causes the cell cycle arrest 
allowing for DNA repair and in the case of repair failure, 
p53 triggers apoptosis [42]. In agreement with the above, 
p53 signaling was activated in all three cell lines in 
response to radiation. Up-regulated BAX (Suppl Table 
1, Fig.2) is known to accelerate programmed cell death 
by binding and inhibiting an apoptosis repressor Bcl-2. 
The activation of sestrin 1 (Suppl Table 1) was previously 
shown upon genotoxic exposure, and its cytoprotective 
function based on regeneration of overoxidized 
peroxiredoxins was described [43]. A few years ago, 
Budanov and Karin showed that sestrin is a target of p53 
and an inhibitor of TOR (target of rapamycin). mTOR is a 
phosphatidylinositol kinase-related kinase that positively 
regulates cell growth. P53-mediated activation of sestrin 
upon genotoxic stress inhibits mTOR through the AMP-
responsive protein kinase (AMPK) [44]. Gene activated 
by p53, the ribonucleotide reductase (RRM2B), was up-
regulated in MCF-7/S0.5 and MCF-7/182R-6 . RRM2B 
plays a role in DNA repair of arrested cells by supplying 
deoxyribonucleotides during cell cycle arrest in a p53-
dependent manner. Although it is not clear whether this 
gene actually affected DNA repair, considering the fact 
that its homolog RRM2 that also provided precursors 
for DNA synthesis was down-regulated in all three cell 
lines). Finally, the increased expression of Gadd45A and 
TP53I3 in antiestrogen-resistant cells also indicate the 
cell cycle arrest after X-ray treatment (Suppl Table 1). 
The gene expression data correlate with the results of the 
annexin V assay on early apoptosis. Exposure to 5 Gy of 
X-rays initiated apoptotic cell death in all three cell lines. 
However, the degree of apoptosis was different in between 
the cell lines. The highest apoptosis level was detected 
in MCF-7/S0.5 cells (30%), while in cells resistant to 
tamoxifen, only 6% of the cells were undergoing apoptosis 
(Fig.5). Such differences can be attributed to the radio-
resistance of MCF-7/TAMR-1 cells. In fact, although the 
response to X-rays (such as an increase in DNA damages 
and cell cycle arrest) in MCF-7/TAMR-1 cells and the 
other two cell lines was similar, MCF-7/TAMR-1 cells did 
not lose their DNA repair capacity and exhibited lower 
fraction of apoptotic MCF-7/TAMR-1 cells compared to 
parental and ICI 182,780 resistant cells. 
According to the gene expression profiling and 
the data of pathway enrichment analysis, a strong down-
regulation of the gap junction pathway was caused by 
the ionizing radiation in MCF-7/S0.5 and MCF-7/182R-6 
but not in MCF-7/TAMR-1 (Table 1). All down-regulated 
genes that constituted the pathway were members of 
cytoskeletal elements, tubulins alpha and beta. An altered 
level of expression of cytoskeletal elements plays a 
considerable role in radiation-mediated transformation. 
The differential modulation of genes encoding cytoskeletal 
elements upon radiation exposure was previously 
documented, where actin and tubulin mRNA accumulation 
was reported to be similar to that in transformed cells 
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[45]. Cancer cells are characterized by a complicated 
ultrastructural organization. Breast cancer cells resistant 
to doxorubicin and cisplatin display an increase in 
the number of microtubules and varying widths of 
microfilaments [46]. Tubulins are critical for cell division, 
which made them a target for several anti-cancer drugs. 
An elevated expression of tubulin correlates with a lack of 
response to chemotherapy. In fact, βIII-tubulin expression 
has been acknowledged as a predictor of the docetaxel 
resistance in metastatic prostate cancer [47]. Another study 
claimed that βII-tubulin is a strong predictor of outcome 
in patients treated with the platinum-based induction 
chemotherapy for locally advanced squamous carcinoma 
of the head and neck [48]. A possible explanation for such 
observation was based on the fact that tubulin binds to the 
voltage-dependent anion channel, VDAC, and regulates 
the permeability of the mitochondrial outer membrane. 
Binding of tubulin to VDAC inhibits the binding of 
proapoptotic drugs which induce a rapid cytochrome c 
release [48]. In the present study, a decrease in tubulin 
expression in the MCF-7/S0.5 and MCF-7/182R-6 cell 
lines indicates the inability of the formation of a tubular 
apparatus necessary for cell division, and it also supports 
the data on early apoptosis. In contrast, MCF-7/TAMR-
1 cells did not show any expression changes in a single 
tubulin gene, which at least partly may contribute to the 
reduced sensitivity to radiation. 
In addition, three genes involved in drug metabolism 
were up-regulated in MCF-7/TAMR-1 cells. One of these 
genes was glutathione S-transferase kappa 1 (GSTK), 
a radical scavenger that is involved in the metabolism 
of xenobiotics. It was previously found that GST plays 
an important role in the acquisition of drug resistance 
through the decreased intracellular drug accumulation 
and the stimulation of drug-induced DNA damage repair 
[49, 50]. Using an in vivo mouse model, it has been 
shown that tamoxifen-resistant tumors had a statistically 
significant increase in GST activity, the increased levels 
of other antioxidant enzymes such as SOD, and the 
reduced glutathione levels [51]. The authors discussed 
the effects of tamoxifen on the intracellular redox status 
of breast cancers, the induction of lipid peroxidation and 
the activation of antioxidant enzymes. Such oxidative 
changes appeared to be tamoxifen-specific as they were 
not found in ICI-resistant tumors [51]. In a recent study, 
a quantitive proteomic analysis revealed up-regulation of 
GST in breast cancer cells during the transition to acquired 
tamoxifen resistance [52]. Taking into consideration that 
ionizing radiation may also influence the redox status 
of cells, we believe that GST may be involved in the 
resistance of cancer cells to radiation, and therefore, may 
be considered one of the common molecular indicators for 
chemo- and radio-resistance. The second gene belonging 
to the drug metabolism pathway was flavin containing 
monooxygenase 5 (FMO). The protein product of this gene 
is an enzyme that belongs to the family of the enzymes 
involved in oxidation and metabolism of xenobiotics. This 
enzyme uses a flavin cofactor for its chemical reactions 
[53]. FMO enzyme system contributes to resistance 
to triclabendazole in liver fluke by metabolizing it to 
triclabendazole sulphooxide [54]. While flavin-containing 
monooxygenases were shown to convert tamoxifen to 
tamoxifen-N-oxide (TNO), TNO may be reduced back to 
tamoxifen by hemoglobin and cytochromes P450 [55]. The 
third gene in the up-regulated drug metabolism pathway 
was monoamine oxidase A (MAOA). MAOA product is an 
enzyme known to degrade amine neurotransmitters, such 
as dopamine, serotonine, epinephrine, and to cause severe 
depression, but was also shown to be involved in the 
metabolism of xenobiotics [56]. The up-regulation of the 
drug metabolism pathway in MCF-7/TAMR-1 cells after 
radiation treatment indicates that ionizing radiation may 
potentially decrease the sensitivity of tamoxifen resistant 
cells to xenobiotics and other treatment modalities (but not 
necessarily only cancer treatments). 
Most recent studies have led to development of 
novel robust algorithms for transcriptome and pathway 
activation analysis. These may in turn be related to the 
potential responsiveness to chemotherapy agents. In 
the future it would be prudent to conduct transcriptome 
pathways profiling using these novels tools [57-59]. 
This study provides the analysis of the roles of 
DNA repair, and apoptosis in response to radiation in 
antiestrogen-sensitive and antiestrogen-resistant cell 
lines. The ability of tamoxifen-resistant cells to retain 
their DNA repair capacity upon radiation treatment allows 
us to suggest that DNA repair genes could possibly be 
considered as putative targets of the future development 
of novel anticancer regimens. Further detailed studies are 
needed to determine the cellular and molecular processes 
that are altered in resistant cells that allow them to survive 
genotoxic treatments such as irradiation. 
MATERIALS AND METHODS
Cell lines and cell culture conditions
The MCF-7/S0.5 (MCF-7), MCF-7/TAMR-1 
(TAMR-1) and MCF-7/182R-6 (182R-6) cell sublines were 
a kind gift from Anne Lykkesfeldt (Breast Cancer Group, 
Cell Death and Metabolism, Danish Cancer Society 
Research Center, DK-2100 Copenhagen, Denmark). 
Subline 0.5 derived from MCF-7 cells was originally 
adapted to grow on 0.5% fetal calf serum [60]. Tamoxifen 
and ICI 182,780 (fulvestrant, Faslodex) resistant sublines 
were derived from MCF-7/S0.5 as described previously 
[61, 62]. MCF-7/S0.5 cells were grown and maintained 
in Dulbecco’s Modified Eagle’s Medium (DMEM /F-12) 
with 2.5 mM L-Glutamine, without HEPES and Phenol 
Red (HyClone, Logan, UT), supplemented with 2% heat-
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inactivated fetal bovine serum (HyClone, Logan, UT) 
and 6 ng/ml of insulin (Sigma-Aldrich Chemical Co., St. 
Louis, MO) at 37 ºC in a 5% CO2 atmosphere. The MCF-
7/TAMR-1 and MCF-7/182R-6 cell lines were grown in 
the identical medium as described above for the MCF-7/
S0.5 line and were additionally supplemented with either 
1 μM tamoxifen (Sigma-Aldrich) or 0.1 μM ICI 182,70 
(Tocris Bioscience), respectively. Cells were harvested for 
analyses by trypsinization.
Irradiation conditions
Cells were irradiated at 80% confluence in 
Dulbecco’s Modified Eagle Medium (DMEM). Two 
radiation doses (0.5 Gy and 5 Gy, 90 kVp, 5 mA) were 
applied to check cellular radiation responses. Unirradiated 
cells served as controls. Cells were harvested 30 minutes 
and 24 hours after irradiation. All treatments were tested in 
triplicate. The experiments were independently reproduced 
twice.
Whole-genome gene expression profiling
RNA isolation
Total RNA was isolated using the Illustra RNAspin 
mini kit (GE Healthcare Life Sciences, Buckinghamshire, 
UK). Approximately 5 x 106 cultured cells were processed 
following the manufacturer’s instructions. Samples were 
eluted in Ultrapure DNase/RNase-free distilled water 
provided in the kit. RNA samples were quantified using 
ultraviolet spectroscopy (NanoDrop, Wilmington, DE) 
and were further assessed for RNA integrity (RIN) on the 
Aglient 2100 Bioanalyzer (Santa Clara, CA) using the 
RNA Nano-chip Kit. RNA samples with RIN values of 
seven or higher were used for further analysis.
Library preparation
cDNA was created using the Ambion’s Illumina 
TotalPrep RNA Amplification Kit (Applied Biosystems, 
Carlsbad, CA) with an input of 500 ng of total RNA per 
sample. Briefly, oligo-dT primers were used to synthesize 
first-strand cDNA containing the phage T7 promoter 
sequence. Single-stranded cDNA was converted into a 
double-stranded DNA template via DNA polymerase. 
Simultaneously, RNase H degraded the RNA. Samples 
of cDNA were purified in the Filter Cartridge to remove 
excess RNA, primers, enzymes, and salts. The recovered 
cDNA was subjected to in vitro transcription using 
biotinylated UTPs. In this step, cRNA was created, 
labeled, and amplified. A final purification step removed 
unincorporated NTPs, salts, inorganic phosphates and 
enzymes, thus preparing samples for hybridization. 
Hybridization and detection
The Illumina’s direct hybridization assay kit was 
used to process samples according to the manufacturer’s 
protocol (Illumina, San Diego, CA). Overnight 750 ng 
of each cRNA sample were hybridized into the Illumina 
HumanHT-12_v4 Whole Genome Expression BeadChip 
arrays. A10-minute incubation in the supplied wash 
buffer at 55ºC preceded a 5-minute room temperature 
wash. The arrays were incubated in 100% ethanol for 
10 minutes. A second room temperature wash lasted two 
minutes with gentle shaking, thus completing this high-
stringency wash. The arrays were blocked with a buffer 
for 10 minutes and washed before a streptavidin-Cy3 
(1:1000) probe for 10 minutes. After a five-minute wash at 
room temperature, the BeadChips were dried and imaged. 
Six controls were also built into the Whole-Genome 
Gene Expression Direct Hybridization Assay system 
to cover the aspects of array experiments, including 
controls for: the biological specimen (14 probes for 
housekeeping controls), three controls for hybridization 
(six probes for Cy3-labeled hybridization, four probes 
for low-stringency hybridization, and one probe for 
high-stringency hybridization), signal generation (two 
probes for biotin control), and approximately 800 probes 
for negative controls on an eight-sample BeadChip. The 
arrays were scanned on the iScan platform (Illumina), and 
the data were normalized and scrutinized using Illumina 
BeadStudio Software.
BeadChip statistical analysis and data processing
The false discovery rate (FDR) was controlled using 
the Benjamini-Hochberg method. The Illumina Custom 
Model took FDR into account and was used to analyze 
the data. Differential gene expression (at least a 0.5-fold 
change) from non-radiated cells was determined to be 
statistically significant if the p value after the adjustment 
using the Benjamini-Hochberg method was lower than 
0.05. The values were transformed to show a log2 scale.
Lists of regulated transcripts were inserted into the 
web-based DAVID Bioinformatics Resources 6.7 (NIAID/
NIH) Functional Annotation Tool [46, 63]. This program 
was used to group genes into functionally relevant 
categories: metabolic processes, responses to stimulus/
stress, DNA repair processes, apoptosis, and cell cycle 
processes. The minimum number of genes in each altered 
pathway has been set to three in order for a pathway to be 
considered for further evaluation. The pathways deemed 
significantly altered if at least 80% of genes were shifting 
the pathway in the same direction [26].
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Quantitative real-time PCR
Quantitative real-time PCR was performed to 
confirm the results of the Whole-Genome Gene Expression 
analysis for the regulation of the direction (either up or 
down) of selected genes. Five genes (CCNA2, CCNB2 
CDC20, PTTG1 and BAX) were selected from the gene 
list of significantly differentially expressed transcripts 
representing a preliminary review of the acquired gene 
expression data. Actin was used as a reference gene. All 
reactions were performed using cDNA synthesized from 
the same RNA extraction as the BeadChip experiments, 
and 500 ng of the sample was used for the Bio-Rad iScript 
Select cDNA Synthesis Kit (Bio-Rad Laboratories, 
Hercules, CA). The samples were stored at -20ºC for 
long-term storage and at 4ºC until they were used for the 
subsequent qRT-PCR reactions.
Primers were designed using the NCBI database 
and PrimerQuest (Integrated DNA Technologies, Inc, 
Coralville, IA). The following primers were designed: the 
forward primer for the ACTA2 reference gene (5’-TAG 
CAC CCA GCA CCA TGA AGA TCA-3’) and the reverse 
primer (5’-GAA GCA TTT GCG GTG GAC AAT GGA-
3’); CCNA2 forward primer (5’-ATG AGC ATG TCA 
CCG TTC CTC CTT-3’) and the reverse primer (5’-TCA 
GCT GGC TTC TTC TGA GCT TCT-3’); CCNB forward 
primer (5’-TGC TTC CTG CTT GTC TCA GAA GGT-
3’) and the reverse primer (5’-CAT TCT TGG CCA TGT 
GCT GCA TGA-3’); CDC20 forward primer (5’-ATG 
CGC CAG AGG GTT ATC AGA ACA-3’) and the reverse 
primer (5’-CAT TTC GGA TTT CAG GCG CAT CCA-
3’); PTTG1 forward primer (5’-AGT GGA GTG CCT 
CTC ATG ATC CTT-3’) and the reverse primer (5’-TCC 
AGG GTC GAC AGA ATG CTT GAA-3’); BAX forward 
primer (5’-TTT CTG ACG GCA ACT TCA ACT GGG-
3’) and the reverse primer (5’- TGT CCA GCC CAT GAT 
GGT TCT GAT-3’). The reactions were prepared using 
1 μL of diluted cDNA, 10 pmol/μL of each forward and 
reverse primer, and SsoFast EvaGreen Supermix (Bio-Rad 
Laboratories, Hercules, CA) prepared according to the 
manufacturer’s instructions. The samples were prepared 
in triplicate and were run on the Bio-Rad C1000 Thermal 
Cycler equipped with the CFX96 Real-Time System. The 
qRT-PCR protocol consisted of denaturation at 95ºC for 
2 minutes; 43 cycles of denaturation (95ºC, 5 seconds) 
and annealing/extension (55ºC, 5 seconds); and a final 
extension at 65ºC for 5 seconds. Annealing temperature 
optimization, melting curve analysis, and gel analysis of 
the amplicon were performed for every set of primers. To 
evaluate PCR efficiency, a standard curve was established 
using a series of cDNA dilutions. The data was captured 
and organized using Bio-Rad CFX Manager 2.1 software 
(Bio-Rad Laboratories, Hercules, CA).
QRT-PCR statistical analysis
The quantification data from the Bio-Rad CFX 
Manager software were analyzed using the Pfaffl method 
in Microsoft Excel [49]. Graphs showing a fold change 
from the untreated cells were created, and transcript 
regulation directions (up- or down-regulation) were 
matched to the results of the Whole-Genome Gene 
Expression analysis.
Immunofluorescence 
For immunocytochemical analysis, cells were 
grown on two-well Lab-Tek chamber slides (Nulge Nunc 
International Corp., Naperville, IL) and irradiated. After 
irradiation, the cells were fixed in 4% paraformaldehyde 
in PBS, permeabilized with 70% ethanol, and washed 
in PBS containing 0.1% TRITON-X100. Blocking was 
done in 8% BSA in PBS. For immunocytochemical 
detection, the cells were incubated for two hours at 
room temperature using an anti-γH2AX (Ser 139) rabbit 
antibody (1:100, Cell Signaling Technology Inc., Danvers, 
MA). Afterwards, the cells were rinsed and incubated with 
a 1:500 diluted secondary antibody - goat anti-rabbit IgG 
Alexa Fluor 488 (Invitrogen Molecular Probes, Eugene, 
OR). Cell nuclei were counterstained with 0.1 mg/mL 
4’,6-diamidino-2-phenylindole dihydrochloride (DAPI) 
(Sigma-Aldrich Chemical Co., St. Louis, MO). The slides 
were mounted with an anti-fade fluorescence medium 
prepared from 1,4-diazabicyclo[2.2.2]octane (DABCO), 
polyvinyl alcohol and glycerol and analyzed using a Zeiss 
epifluorescent microscope.
The number of γH2AX foci per cell was counted 
in at least 2`00 cells from each cell group, as previously 
described [50]. The levels of γH2AX were represented as 
the mean ± SE; P ≤ 0.05.
Alkaline Comet Assay
The alkaline comet assay protocol was based on 
Olive and Bannath (2006) and Tice and Vasques (1995) 
at cometassay.com [64, 65]. The cells that were grown in 
cultures were trypsinised, collected in 15-ml tubes, and 
centrifuged for three min at 1000 g to form a pellet. Next, 
the pellet was washed three times with ice-cold phosphate-
buffered saline (PBS) without -Ca2+ and -Mg2+. Finally, 
the cells were resuspended in their final concentration of 
1000 cells per 1 µL of cell suspension in ice-cold PBS. 
The cell suspension was stored on ice during the course of 
subsequent procedures.
Ten microliters of cell suspension were mixed with 
75 ul of 1% low melting point (LMP) agarose pre-heated 
to 40 ºC, mixed gently through pipetting up and down, 
and applied to a fully frosted microscope slide (VWR) 
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that was pre-coated with normal melting point agarose. 
The agarose was overlaid with a cover slip and allowed 
to solidify for two to three minutes on ice. The removal of 
the cover slip was followed by an application of 85 ul of 
1% LMP agarose pre-heated to 40 ºC in order to form a 
protective layer on the top of the layer containing the cell 
suspension. The cover slip was repositioned, and the slides 
were placed on ice to allow the agarose to solidify. 
The cover slips were removed, and the slides were 
placed in a freshly prepared alkaline lysis solution (2.5 M 
NaCl, 100 mM Na2EDTA, 10 mM Tris base, 1% Triton, 
and 0.1% Sodium Lauroyl Sarcosine (pH 10.0) adjusted 
to 4 ºC), left overnight at 4 ºC, and protected from light. 
Following the lysis step, the slides were rinsed with 
a freshly prepared electrophoresis solution (300 mM, 
2mM EDTA (pH>14)). Next, the slides were placed in an 
electrophoresis tank, covered with a thin layer (1-2 mm) 
of electrophoresis buffer, and left for 30 min to permit 
alkaline DNA unwinding. Electrophoresis was performed 
for 25 minutes at 0.7 V/cm. Each electrophoresis included 
slides that belonged to the same experimental time-point. 
After the completion of electrophoresis, the 
slides were washed three times for five minutes in a 
neutralization buffer (0.4 M Tris (pH=7.5)). The slides 
were stained with SYBR gold dye (Invitrogen), the comets 
were viewed using a epifluorescence microscope (Zeiss), 
and the image information was collected using a Comet 
Assay IV system (Perceptive Instruments).
The statistical analysis was performed to obtain 
the tail intensity data using SPSS software (IBM) and 
according to recommendations on the statistical analysis 
of the Comet assay [37]. The data was collected from 
three replicate cell culture flasks, at two slides per flask, 
and 50 cells were examined on each slide. The median 
of the log tail intensity from 50 cells was evaluated per 
each slide followed by the calculation of the mean of two 
medians from two slides derived from one cell culture 
flask. Finally, the mean values were compared between 
three flasks representing each treatment point using a one-
way ANOVA. The levels of tail intensity were represented 
as mean ± SD; P ≤ 0.05. 
The Annexin V assay 
For the early detection of apoptosis, an Annexin 
V-FITC Apoptosis Detection Kit I (BD Biosciences, 
San Jose, CA) was used according to the manufacturer’s 
protocol. Cells were grown and irradiated as previously 
described (Section 2.2). The analysis was performed 24 
hours after exposure to radiation. Cells were harvested, 
washed with PBS, resuspended in a 1X binding buffer, 
stained with Annexin V and propidium iodide for 15 min 
at 25 ºC in the dark, and analyzed using flow cytometry 
within one hour at the Flow Cytometry Core Facility 
(University of Calgary, Calgary, AB). The results were 
represented as a percentage of gated Annexin V positive 
cells.
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